Literature DB >> 30352219

CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.

Longxi Mao1, Shilian Le1, Xin Jin1, Guoliang Liu1, Jun Chen1, Junwen Hu2.   

Abstract

COP9 signalosome subunit 5 (CSN5) has been involved in the progression of diverse human cancers. MMP2 plays an important role in the metastasis of cancer cells. However, the roles and relationship of in pancreatic cancer (PC) is still unknown. Here, our data shown that both CSN5 and MMP2 were significantly upregulated in PC compared with the corresponding adjacent tissues, where a positive correlation in their expression and associated malignant characteristics were found. Further, silencing of CSN5 expression markedly inhibited PC invasion and metastasis in vitro and in vivo, accompanied by decreased MMP2 expression. Moreover, the anti-metastasis role of CSN5 silence was reversed by MMP2 overexpression, whereas knockdown of MMP2 decreased PC metastasis driven by upregulation of CSN5. Further investigation revealed that CSN5 regulated MMP2 expression via activation of FOXM1 in PC cells. Mechanistically, CSN5 directly bound FOXM1 and decreased its ubiquitination to enhance the protein stability of FOXM1. Taken together, the results indicate that CSN5 can contribute to PC invasion and metastasis through activation of FOXM1/MMP2 axis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CSN5; FOXM1; MMP2; Metastasis; Pancreatic cancer

Mesh:

Substances:

Year:  2018        PMID: 30352219     DOI: 10.1016/j.yexcr.2018.10.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  LNC00673 suppresses proliferation and metastasis of pancreatic cancer via target miR-504/ HNF1A.

Authors:  Yi Gong; Hai-Su Dai; Jun-Jie Shu; Wei Liu; Ping Bie; Lei-da Zhang
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

Review 2.  Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression?

Authors:  Etienne J Slapak; JanWillem Duitman; Cansu Tekin; Maarten F Bijlsma; C Arnold Spek
Journal:  Biology (Basel)       Date:  2020-04-18

3.  Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p.

Authors:  Shan Li; Qian Zhang; Wen Liu; Chunbo Zhao
Journal:  BMC Cancer       Date:  2021-03-18       Impact factor: 4.430

Review 4.  Targeting the COP9 signalosome for cancer therapy.

Authors:  Wenqi Du; Ruicheng Zhang; Bilal Muhammad; Dongsheng Pei
Journal:  Cancer Biol Med       Date:  2022-03-21       Impact factor: 5.347

5.  Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis.

Authors:  Yonghua Guo; Meng Gao; Ye Yao; Jinghua Li; Xi Chen; Xingxing Wang; Zhang Chen; Yufeng Yuan; Weijie Ma
Journal:  BMC Cancer       Date:  2022-07-23       Impact factor: 4.638

Review 6.  Impact of posttranslational modifications in pancreatic carcinogenesis and treatments.

Authors:  Nianhong Chen; Qiaoqiao Zheng; Guoqing Wan; Feng Guo; Xiaobin Zeng; Ping Shi
Journal:  Cancer Metastasis Rev       Date:  2021-08-03       Impact factor: 9.264

7.  MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5.

Authors:  Balu Wu; Yunbao Pan; Guohong Liu; Tian Yang; Yanxia Jin; Fuling Zhou; Yongchang Wei
Journal:  Front Oncol       Date:  2019-11-07       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.